Evaluating with these data, the range of previously reported incidence rates of pregnancy-connected ICH is certainly 3.8 to 18.1 per 100,000 deliveries. Yoshimatsu recently reported a straight lower incidence price of pregnancy-associated ICH in Japan weighed against the above-pointed out data at 3.5 cases per 100,000 deliveries. Second, the mortality price of ICH during pregnancy and the puerperium in today’s study was also higher than in previous research. In Japan, the mortality of such individuals is as high as 18.4 percent. On the other hand, in today’s study, there have been 12 maternal deaths, providing a case mortality price of 30.77 percent. These data were consistent with previously reported data in China. One possible reason behind these data features is definitely that the Beijing Tiantan hospital in which the studied data had been collected is the medical transport center for pregnant and maternal patients with essential craniocerebral disease in Beijing.All the patients provided written informed consent. Consent for continued participation was also obtained from patients who had a confirmed progression or relapse of disability. The study was authorized by the relevant central and regional ethics committees and was carried out relative to the International Conference on Harmonisation guidelines for Good Clinical Practice and the principles of the Declaration of Helsinki. S1 in the Supplementary Appendix). Individuals continuing treatment up to week 144 or until the last enrolled patient completed week 96, which was the planned end of the analysis.